Novo Nordisk, Dr. Reddy's emerge with partial wins in India's semaglutide patent suit
Dr. Reddy’s won permission to export semaglutide after an Indian court found that the domestic pharma company had raised a credible challenge to Novo Nordisk’s patent. However, the Delhi High Court...To view the full article, register now.
Already a subscriber? Click here to view full article